Table 2.
Correlation of EHF expression to clinicopathological features in PDAC
ParametersEHF (n)χ2PSpearman r
LowHigh
Age (yr) 
<60 35 12 0.306 0.580 0.056 
≥60 34 15    
Sex 
Male 36 16 0.392 0.531 −0.064 
Female 33 11    
Histological grade 
G1, G2 40 23 6.371 0.012a −0.258 
G3 29    
pTNM stage 
IA, IB 14 11 4.214 0.040a −0.210 
IIA, IIB 55 16    
CD8 
≤20/HP 53 10 13.609 0.000a 0.377 
>20/HP 16 17    
T reg cell 
≤20/HP 27 20 9.483 0.002a −0.314 
>20/HP 42    
MDSC 
≤10/HP 17 13 4.993 0.025a −0.228 
>10/HP 52 14    
ParametersEHF (n)χ2PSpearman r
LowHigh
Age (yr) 
<60 35 12 0.306 0.580 0.056 
≥60 34 15    
Sex 
Male 36 16 0.392 0.531 −0.064 
Female 33 11    
Histological grade 
G1, G2 40 23 6.371 0.012a −0.258 
G3 29    
pTNM stage 
IA, IB 14 11 4.214 0.040a −0.210 
IIA, IIB 55 16    
CD8 
≤20/HP 53 10 13.609 0.000a 0.377 
>20/HP 16 17    
T reg cell 
≤20/HP 27 20 9.483 0.002a −0.314 
>20/HP 42    
MDSC 
≤10/HP 17 13 4.993 0.025a −0.228 
>10/HP 52 14    

Data were based on tissue IF assay. Statistical data on EHF expression in relation to clinic-histopathologic features for surgical PDAC specimens. P values were calculated using the χ2 test.

a

Statistically significant (P < 0.05).

or Create an Account

Close Modal
Close Modal